巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Dermata Therapeutics

    DRMA
    0.886
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Dermata Therapeutics - 延遲價格・最後更新於 27/05 8:25
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    0.886
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    8.17
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    6.950 - 0.620
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Dermata Therapeutics
    證券代碼
    DRMA.US
    所屬板塊
    Biotechnology
    公司業務
    Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
    發行量
    8328629
    公司總部
    3525 Del Mar Heights Road, Suite No. 322
    公司網址
    https://www.dermatarx.com
    公司電話
    +1 858 800-2543
    暫無內容

    關於

    Dermata Therapeutics(DRMA.US)所屬的行業板塊為Biotechnology。
    Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
    詳細公司背景可參考: https://www.dermatarx.com